Thus, the ability of MSCs to improve the integrity of the BBB in ischemic stroke could be explained in part by a reduction in the infiltration of neutrophils into the lesion and, consequently, the reduced release of MMP-9 from these cells. This evidence concerns the gene MMP9 and ischemic stroke.